Resilience is engaged in the manufacturing of cell and gene therapies, vaccines, biologics, and nucleic acids. Resilience partners with other firms in order to help them develop and scale their products.
- Media news
- Corp news
- Combo news
The data in the chart above is based on data derived from our proprietary XP calculation model and may be changed, adjusted and updated without prior notice
- Share Price
- Cumulative Funding
The data in the tables and charts is based on data from public sources and although we make every effort to compile the data, it may not coincide with the actual data of the issuer.
*** - To view the data, please log into your account or create a new one.
News related to Resilience
As US plots biomanufacturing boost, National Resilience nets $410M loan from Defense Department
Resilience will channel the cash toward its goal of building biomanufacturing capacity and capabilities on U.S. soil ...https://www.fiercepharma.com/manufacturing/white-house-eyes-biomanufacturing-boost-local-producer-national-resilience-adds-410m